Remove 2026 Remove Immunization Remove Patient Care
article thumbnail

Expert Discusses McKesson's Approach to Supporting Community Pharmacies | McKesson ideaShare

Drug Topics

"I think it's really important, as we move to 2026 and beyond, we figure out ways to help pharmacies ease that burden and diversify their business." Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips. Subscribe Now!

article thumbnail

Passport to Protection: Best Practices for Travel Vaccines in the Pharmacy Setting

Drug Topics

The Immunization Action Coalition also has a travel vaccine section on its website with many resources. Depending on the pharmacy practice act for your state, you may or may not be able to provide all vaccinations recommended by the Advisory Committee on Immunization Practices. 2026 Edition. The Immunization Action Coalition.

Vaccines 341
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hair Loss Therapy Shows Potential for Regeneration in Phase 2 Trial

Drug Topics

Positive results have been announced from a phase 2a clinical trial evaluating the safety, pharmacokinetics and efficacy of PP405 for the treatment of androgenetic alopecia in adult patients, Pelage Pharmaceuticals announced in a release. 1 The company said it plans to initiate phase 3 studies in 2026 to further evaluate the therapy.

article thumbnail

Reflecting on 2024: A Year of Progress in Advancing Quality

PQA

Payers are eager to engage pharmacies in driving better patient care and outcomes, but for this effort to be successful, consistent and reliable methods are needed to measure pharmacists contributions to care. Results from this two-year project will be shared in 2026.

article thumbnail

FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1

Drug Topics

The FDA has accepted for review a New Drug Application (NDA) for doravirine/islatravir for adult patients with HIV-1 infection that is virologically suppressed on antiretroviral therapy, Merck announced in a release. 1 The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026. References 1. Subscribe Now!

FDA 247
article thumbnail

Turning Reconciliation into a Revenue Growth Engine

Drug Topics

With rising drug costs, evolving health care regulations, and challenging reimbursement models, pharmacies must adopt strategic approaches to maintain financial health and continue providing patient care.

article thumbnail

Pneumococcal Burden Remains Despite Immunization Expansion

Drug Topics

1 The Advisory Committee on Immunization Practices voted to lower the pneumococcal recommendation to 50 years in October 2024. Previously, the vaccination recommendation was for patients 65 years and older, but the CDC Advisory Committee on Immunization Practices (ACIP) voted to lower the recommendation to 50 years in October 2024.